CE1: UNDERSTANDING ACCULTURATION: AN IMPORTANT CONCEPT FOR NURSING CARE
Leorey N. Saligan, PhD, CRNP
There is an increasing demand to understand the concept of acculturation as nursing moves forward in providing holistic, culturally sensitive, and quality care in multicultural societies
At the conclusion of this educational activity, participants should be able to:
- Describe and understand the concept of acculturation.
- Indicate two reasons why assessment of acculturation is necessary and demonstrate their clinical utilization in the effective management of specific cultural groups.
- Identify three antecedents of acculturation.
- Summarize the consequences of acculturation to the health of an individual.
This activity is eligible for credit through April 3, 2011. After this date, this activity will expire and no further credit will be awarded.
There are no fees for participating in this activity.
Leorey N. Saligan, PhD, CRNP
Assistant Clinical Investigator
National Institute of Nursing Research
National Institutes of Health
Dr. Leorey Saligan is a Associate Clinical Investigator at the National Institute of Nursing Research, Intramural Research Program. Dr. Saligan is a principal investigator of several NIH studies exploring valid and reliable clinical measures of fatigue and understanding the role of physiological stress and immune responses in the experience of fatigue.
His research focus is determining a deeper understanding of the molecular-genetic mechanisms involve in perceived fatigue and finding how these mechanisms can be utilized to alleviate fatigue symptoms from patients using innovative interventions. He is a licensed and practicing family nurse practitioner. He obtained his MS and PhD in nursing degrees from Hampton University.
XXX is approved by the California Board of Registered Nursing, Provider Number CEPXXXX. XXX designates this CNE activity for 1.0 contact hour.
In accordance with the California Board of Nursing, PNAA, requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. Accordingly the following disclosures were made.
The presenting faculty reported the following:
Dr. Leorey Saligan has disclosed that he has no significant relationships with the grantors or any other commercial company whose products and services may be related to her presentation.
Planner and Provider Financial Disclosure
The PNAA Journal Editorial Staff who were involved in the development of this activity have no financial relationships with any commercial interests that are relevant to this activity.
Conflict of Interest Resolution
To resolve identified conflicts of interest, the educational content was fully peer reviewed by members of the PNAA Journal Editorial Staff. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.
In accordance with PNAA policy, the audience is advised of the following disclosures regarding unlabeled or unapproved uses of drugs or devices:
Dr. Saligan indicated that his presentation would not include the discussion of unlabeled uses of commercial products or investigational products not yet approved by the FDA for any use in the United States.